{"id":"W4237085286","doi":"10.1016/j.jval.2017.08.2987","title":"Patient-Reported Outcomes from Phase 3 Baricitinib Ra-Beam Study: Latin American Subgroup Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Visual analogue scale; Continuous variable; Rheumatoid arthritis; Placebo; Internal medicine; Physical therapy; Imputation (statistics); Categorical variable; Methotrexate; Missing data","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002382612,0.0009533987,0.00248301,0.001135719,0.0003399896,0.001202574,0.0006260763,0.0006528209,0.00204029],"category_scores_gemma":[0.003261108,0.0003169121,0.006419131,0.001932855,0.0003032404,0.0005295767,0.0009288976,0.001045156,0.0002238528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006512841,"about_ca_system_score_gemma":0.0007989731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005480615,"about_ca_topic_score_gemma":0.0125741,"domain_scores_codex":[0.9982321,0.0006567816,0.0002621287,0.0003312947,0.0002055255,0.000312175],"domain_scores_gemma":[0.9989795,0.0003684713,0.000315609,0.0001483341,0.0001149073,0.00007319835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06992275,0.0004112797,0.7125812,0.003038446,0.16812,0.0005827796,0.0003696497,0.001450403,0.002813624,0.000616057,0.007733047,0.03236084],"study_design_scores_gemma":[0.01781759,0.002381401,0.8326594,0.0005787613,0.1321504,0.0005569688,0.001283631,0.002623453,0.0007648883,0.001388936,0.007665979,0.0001285569],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9707689,0.01829271,0.0009387971,0.0005432756,0.0001885551,0.0002247698,0.006421566,0.00004104668,0.002580464],"genre_scores_gemma":[0.9934142,0.001532326,0.0002229591,0.0005367626,0.0001225889,0.0002365905,0.003306301,0.00002522705,0.0006030278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005480615,"threshold_uncertainty_score":0.0126006,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06214276786185622,"score_gpt":0.3830369414305725,"score_spread":0.3208941735687163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}